CIDR 1.38G VAGINAL DELIVERY SYSTEM FOR CATTLE
Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Caracteristicilor produsului
(SPC)
29-04-2024
Unele documente pentru acest produs nu sunt disponibile în prezent, puteți trimite o solicitare la serviciul nostru pentru clienți și vă vom anunța de îndată ce vom putea să le obținem.
Trimite cerere.
Trimite cerere.
Ingredient activ:
PROGESTERONE
Disponibil de la:
Pfizer Healthcare Ireland
Codul ATC:
QG03DA04
Dozare:
1.38 Grams
Forma farmaceutică:
Vaginal Delivery System
Grupul Terapeutică:
Hormone
Zonă Terapeutică:
Bovine
Data de autorizare:
2008-02-22
Caracteristicilor produsului
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CIDR 1.38g Vaginal Delivery System for Cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE(S):
Each device contains Progesterone. 1.38 g.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Vaginal delivery system.
A “T” shape device consists of progesterone impregnated silicone elastomer skin moulded over an inert nylon spine.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (cows and heifers).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the control of the oestrous cycle in cycling cows and heifers, including:
- Synchronisation of oestrus in groups of animals.
- Synchronisation of donor and recipient animals for embryo transfer.
To be used in combination with prostaglandin F2
or analogue.
Use as recommended normally results in oestrus 48-96 hours after device removal with the majority of animals
showing oestrus within 48-72 hours.
4.3 CONTRAINDICATIONS
Do not use:
- in cows or heifers, with abnormal or immature genital tracts, or with genital infections.
- in pregnant cattle.
- within the first 35 days after calving.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The progesterone treatment alone, according to dosage regimen proposed, is not sufficient to induce oestrus and ovulation
in all cycling females. It is advisable to confirm cycling ovarian activity before using the progesterone treatment.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 01/03/2012_
_CRN 7012064_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL WARNINGS FOR USE IN ANIMALS
Animals in poor condition, whether from illness, inadequate nutrition, or other factors, may respond poorly to treatmen
Citiți documentul complet
